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In July 2010, we identified an outbreak of vancomycin-resistant enterococci (VRE) in our 
26-bed neonatal intensive care unit. We performed an epidemiological investigation after 
clinical cultures of 2 neonates were positive for VRE. Identification, susceptibility testing, 
and molecular characterization were performed. Cultures of 3 surveillance stool samples 
of inpatients and 5 environmental samples were positive for VRE. All isolates were identi-
fied as Enterococcus faecium containing the vanA gene. Two distinct clones were identi-
fied by performing pulsed-field gel electrophoresis. The 2 clones exhibited different pulso-
types, but they represented identical Tn1546 types. Two sequence types, ST18 and ST192, 
were identified among all of the isolates with multilocus sequence typing. Our investigation 
determined that the outbreak in the neonatal intensive care unit was caused by 2 geneti-
cally different clones. The outbreak may have occurred through clonal spread and hori-
zontal transfer of the van gene. 
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INTRODUCTION
Vancomycin-resistant enterococci (VRE), which have been es-
tablished as important nosocomial pathogens worldwide [1], 
have become endemic in a number of hospitals. VRE coloniza-
tion of the gastrointestinal tract, which usually precedes infec-
tion, may persist for long periods and serve as silent reservoirs 
for colonization in other patients [2, 3]. Dissemination of vanco-
mycin resistance can occur through both clonal expansion of 
VRE and horizontal transfer of van genes to other bacteria [4]. 
Currently, multiple clones of vancomycin resistance genes and 
their horizontal transmission are commonly encountered. VRE 
infection among neonates appears to be quite rare because ex-
ternal contact is limited due to the restricted access to neonatal 
intensive care units (NICU). Therefore, the major cause of VRE 
transmission in the NICU is the indirect spread of VRE by health 
care personnel or through contaminated environments. Asymp-
tomatic patients with VRE colonization can serve as continuing 
reservoirs because healthcare workers may not adequately 
wash their hands between contacts with different neonates. 
Risk factors for VRE colonization in neonates include low birth 
weight, prematurity, and long-term antimicrobial therapy [5]. 
Most neonatal VRE infections have been associated with clus-
ters and outbreaks [5-8].
  Since the first isolation of VRE in our institution in 1996, the 
prevalence of VRE has dramatically increased. In the NICU, 
however, VRE infections have been rarely reported, and all of 
them were sporadic cases until 2010. We describe, herein, a 
VRE outbreak that was caused by 2 genetically different clones 
in the NICU and the clinical presentations, the interventions 
used to control the spread of VRE, and the molecular epidemio-
logic investigation. Lee WG, et al.
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CASE REPORT
This study was conducted in a 1,000-bed university hospital. The 
NICU ward has 2 rooms with 26 beds, as shown in Fig. 1. The 
NICU is staffed by 1 pediatrician, 5 residents, and 29 nurses who 
provide care for critically ill patients of age less than or equal to 6 
months. All healthcare workers practice standard precautions. In 
July 2010, VRE was isolated from a sputum sample of a prema-
ture neonate (Index Case 1). Subsequently, VRE was isolated 
from a urine culture of another neonate (Index Case 2). 
1. CASE
1) Case 1 (Index case 1)
A 780-g baby boy, who was the first born of a set of twins, was 
born by normal spontaneous vaginal delivery (NSVD) to a G1P0 
21-yr-old mother at 25 weeks of gestation. Apgar scores were 2 
and 3 at 1 and 5 min, respectively. After birth, he received sur-
factant treatment because he had developed a number of com-
plications of prematurity such as respiratory distress requiring 
mechanical ventilation and oxygen therapy. He was adminis-
tered ampicillin-sulbactam until his primary cultures were nega-
tive. On the 5th day in the NICU, he developed abdominal dis-
tension, and an X-ray radiograph of his abdomen showed the il-
eus sign indicating necrotizing enterocolitis (NEC). On the 8th 
day, he underwent small bowel resection for bowel perforation, 
and on the 15th day, he developed pulmonary hemorrhage and 
intraventricular hemorrhage. On the 31st day, a sputum sample 
was obtained, and the sputum culture grew VRE. Ampicillin-sul-
bactam was replaced with ceftriaxone and linezolid. Although 
the sputum culture stopped growing VRE on the 36th day, VRE 
continued growing in cultures obtained from rectal swab sam-
ples. On the 77th day, he started feeding training, but bile regur-
gitation was observed, and bowel obstruction was suspected. 
He underwent exploratory laparatomy, and small bowel resec-
tion was performed. On the 135th day, feeding training was re-
started, but bile regurgitation was observed again. An imaging 
study showed that the NEC had aggravated, and metabolic aci-
dosis and pneumonia had developed. On the 142nd day, he 
died due to multiple organ failure and sepsis. Stool cultures re-
mained positive for VRE throughout his hospitalization.
2) Case 2 (Index case 2)
A 2,300-g baby boy was born to a G1P0 27-yr-old mother at 36 
weeks of gestation by NSVD. Apgar scores were 8 and 9 at 1 
and 5 min, respectively. His health conditions during the first 
week were uneventful. On the 7th day after his birth, he showed 
lethargy and poor oral intake. He was diagnosed with aseptic 
meningitis, disseminated intravascular coagulation, and neona-
tal jaundice on the basis of initial laboratory test results. He was 
admitted to the NICU and received vancomycin and ceftriaxone 
for 7 days. On the 6th day of his hospital stay, he developed bra-
dycardia and exhibited increased cardiac enzyme levels with an 
Fig. 1. Map of the neonatal intensive care unit showing the location of the patients with vancomycin-resistant enterococci (VRE). Num-
bered rectangles, location of beds inside the room; Gray rectangles, environmental locations that showed presence of VRE.Lee WG, et al.
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ejection fraction of 19%, which resulted in the diagnosis of myo-
carditis. Urine and rectal swab samples were collected on the 
18th and 23rd day, and cultures of these samples grew VRE. 
The patient initially received vancomycin and ceftriaxone; these 
were then replaced with ampicillin-sulbactam. Blood cultures 
and urine cultures were negative after 1 week of ampicillin-sul-
bactam treatment and for 1 week after discontinuation of the 
ampicillin-sulbactam treatment. The patient’s clinical condition 
improved, and no complications were observed. On the 28th 
day, the patient was discharged, and echocardiography per-
formed at 2 months later revealed a normal ejection fraction 
(61%). 
2. Intervention
Immediately after the occurrence of the second case of VRE, a 
special team was formed to coordinate the management of the 
outbreak. We performed active surveillance cultures for VRE on 
samples from all of the 26 NICU patients, 42 health care work-
ers, and their environments. Environmental samples were col-
lected on swabs moistened with sterile saline from multiple sites 
in the NICU. All patients who were identified with VRE were 
placed in strict cohorting. Infection control measures were 
strengthened, and all patient areas were thoroughly cleaned. 
Screening was repeated every week until VRE-positive patients 
were present in the NICU.
3. Microbiology study
Organisms were identified by conventional biochemical reac-
tions with the Vitek identification system (bioMérieux, Inc., Ha-
zelwood, MO, USA) and with the API Strep system (bioMérieux, 
Inc.). All isolates were typed by performing pulsed-field gel elec-
trophoresis (PFGE) on a CHEF-DR III apparatus (Bio-Rad Labo-
ratories, Inc., Richmond, VA, USA). After digestion with SmaI, 
genomic DNA was separated by performing electrophoresis with 
ramped pulse times of 5–30 sec at 6 V/cm for 19 hr. The band-
ing patterns were interpreted according to Tenover et al. [9]. 
The vancomycin resistance genotypes were determined by per-
forming PCR with primers that were specific for the sequences 
of the vanA, vanB, vanC1, and vanC2/C3 genes, as described 
previously [10].
Isolates were characterized by their Tn1546 elements. DNA was 
extracted with the QIAGEN DNeasy Kit (QIAGEN GmbH, Hilden, 
Germany) according to the manufacturer’s instruction. For the 
structural analysis of Tn1546, overlapping PCR amplification of 
the internal regions of the elements was performed, as de-
scribed previously [11]. The purified PCR products were directly 
sequenced on an ABI Prism 3100 DNA SEQUENCER (Applied 
Biosystems, Foster City, CA, USA) and analyzed using DNASIS 
for Windows v.2.6 (Hitachi Solutions America, Ltd., South San 
Francisco, CA, USA). 
  Multilocus sequence typing (MLST) was performed according 
to the protocol previously described [12]. Internal fragments of 7 
housekeeping genes (adk, atpA, ddl, gdh, gyd, purK, and pstS) 
were amplified by PCR and directly sequenced. The allele num-
ber for each gene was assigned according to the Enterococcus 
faecium MLST database (http://www.mlst.net). The combination 
of the allelic sequences for the 7 genes yielded the allelic profile 
or sequence type (ST) for each isolate.
  Cultures of 6 sputum samples of index case 1 and 2 and 
urine samples of index case 2 were positive for VRE. Cultures of 
3 surveillance stool samples of inpatients and 5 environmental 
samples were positive for VRE. All surveillance cultures of medi-
cal staff were negative for VRE. Culture-positive samples from 
the environment were obtained from the door handle of isolation 
room 1, the shelves of storage room 2, and the tables of the of-
fice and treatment room (Fig. 1). The strengthened infection 
control measures were terminated after 2 months during which 
no additional new cases were detected. All subsequent environ-
mental VRE cultures were negative. 
  All isolated VREs were E. faecium, and PCR analysis showed 
that the resistance gene was vanA. PFGE, MLST, and the struc-
tural analysis of Tn1546 were performed for 16 isolates. The ob-
tained results are summarized in Table 1. Using PFGE, we iden-
tified 3 clones of VRE: clone A, clone B1, and clone B2 (Fig. 2). 
Table 1. Microbiological features of vancomycin-resistant isolates
Serial 
No. Source of specimen
Date of 
isolation 
(mm/dd)
vanA 
PCR
PFGE 
pattern
Sequence 
type
Transposon 
type
1-6 Sputum of index case 1
07/07-
08/19
+ A ST18 P
7 Urine of index case 2 07/09 + A ST18 P
8 Urine of index case 2 07/14 + B1 ST192 P
9 Stool of contact patient 1 07/15 + A ST18 P
10 Stool of contact patient 2 07/15 + B1 ST192 P
11 Stool of contact patient 3 07/15 + B2 ST192 P
12 Environment 07/15 + A ST18 P
13 Environment 07/15 + A ST18 P
14 Environment 07/15 + A ST18 P
15 Environment 07/15 + B1 ST192 P
16 Environment 07/15 + B1 ST192 P
Abbreviations: PFGE, pulsed-field gel electrophoresis; ST, sequence type.Lee WG, et al.
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Clones B1 and B2 had 4 band differences and were included in 
the genetically related category. Of the 16 isolates, 11 belonged 
to clone A, 4 belonged to clone B1, and 1 belonged to clone B2. 
Six isolates obtained from index case 1 exhibited identical PFGE 
profiles (clone A). However, the PFGE patterns of the 2 isolates 
obtained from index case 2 were different from one another; the 
first isolate belonged to clone A, and the second isolate be-
longed to clone B1.  
  Genotyping of all of the isolates by MLST revealed 2 different 
STs; of the 16 isolates, 11 were ST18 and 5 were ST192. The 
structural analysis of Tn1546 showed that all isolates had identi-
cal Tn1546 type. The type represented 2 copies of IS1216V at 
the left end of Tn1546 and in the vanX-vanY intergenic region as 
well as IS1542 in the orf2-vanR intergenic region. 
DISCUSSION
Our results show that the VRE outbreak in the NICU was caused 
by 2 genetically different VRE clones. The index case 1 was 
identified on July 7, 2009, and Clone A was responsible for in-
dex case 2, VRE carriage (as detected in 1 case) and environ-
mental contamination (as detected in 3 samples). The index 
case 2 was identified on July 9, 2009, and clone B1 was respon-
sible for VRE carriage (as detected in 2 cases) and environmen-
tal contamination (as detected in 2 samples). 
  There were 2 predominant clones in the NICU. These 2 
clones had different PFGE profiles but identical Tn1546 type. 
Two different STs, namely, ST18 and ST192 were identified 
among all isolates. ST18 and ST192 are double-locus variants of 
ST17, which was the founder of the clonal complex 17 (CC17). 
Most nosocomial E. faecium strain types that are associated 
with outbreaks belong to a single clonal complex called the 
CC17 lineage [13-15]. CC17 dissemination appears to have pre-
ceded the emergence of vancomycin resistance, as shown by 
its predominance in hospitals throughout the world [16, 17]. 
  Our results suggested that the outbreak occurred through 
clonal spread and horizontal transfer of the van gene. At first, 
the dissemination of VRE from index case 1 to index case 2 oc-
curred through clonal expansion. While index case 2 harbored 
VRE acquired from index case 1, horizontal transfer of Tn1546 
to other E. faecium occurred in the gastrointestinal tract of index 
case 2. Because infant-to-infant spread of VRE did not occur, 
VRE might have been transmitted indirectly through contact 
with health care personnel or through contaminated environ-
ment. Index case 1 carried VRE in his intestine throughout his 
hospitalization. However, after intervention, no new VRE cases 
were detected, and all subsequent environmental samples were 
negative for VRE. Our results suggest that VRE spread can be 
prevented by adopting intensive infection control measures, 
even if VRE carriers are present. Once VRE is colonized, the 
clearance of carriers is difficult to achieve. There is currently no 
effective VRE decolonization regimen. However, enforcing clean-
ing measures and encouraging hand hygiene and strict cohort-
ing can prevent the spread of VRE in hospitals. Early interven-
tions are associated with a high likelihood of controlling hospital 
outbreak. Thus, at the onset of an outbreak, the possibility of 
environmental contamination should be considered, and mea-
sures to tackle environmental contamination should be adopted.
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